Literature DB >> 30050162

The hepatitis B epidemic and the urgent need for cure preparedness.

Jeffrey V Lazarus1, Timothy Block2, Christian Bréchot3, Anna Kramvis4, Veronica Miller5, Michael Ninburg6, Capucine Pénicaud7, Ulrike Protzer8, Homie Razavi9, Laura A Thomas10, Jack Wallace11, Benjamin C Cowie10,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30050162     DOI： 10.1038/s41575-018-0041-6

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  6 in total

1.  A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape Mutations.

Authors:  Qiao Wang; Eleftherios Michailidis; Yingpu Yu; Zijun Wang; Arlene M Hurley; Deena A Oren; Christian T Mayer; Anna Gazumyan; Zhenmi Liu; Yunjiao Zhou; Till Schoofs; Kai-Hui Yao; Jan P Nieke; Jianbo Wu; Qingling Jiang; Chenhui Zou; Mohanmmad Kabbani; Corrine Quirk; Thiago Oliveira; Kalsang Chhosphel; Qianqian Zhang; William M Schneider; Cyprien Jahan; Tianlei Ying; Jill Horowitz; Marina Caskey; Mila Jankovic; Davide F Robbiani; Yumei Wen; Ype P de Jong; Charles M Rice; Michel C Nussenzweig
Journal:  Cell Host Microbe       Date:  2020-06-05       Impact factor: 21.023

2.  A global scientific strategy to cure hepatitis B.

Authors:  Peter A Revill; Francis V Chisari; Joan M Block; Maura Dandri; Adam J Gehring; Haitao Guo; Jianming Hu; Anna Kramvis; Pietro Lampertico; Harry L A Janssen; Massimo Levrero; Wenhui Li; T Jake Liang; Seng-Gee Lim; Fengmin Lu; M Capucine Penicaud; John E Tavis; Robert Thimme; Fabien Zoulim
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

Review 3.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

4.  The Dihydroquinolizinone Compound RG7834 Inhibits the Polyadenylase Function of PAPD5 and PAPD7 and Accelerates the Degradation of Matured Hepatitis B Virus Surface Protein mRNA.

Authors:  Liren Sun; Fang Zhang; Fang Guo; Fei Liu; Jessie Kulsuptrakul; Andreas Puschnik; Min Gao; Rene Rijnbrand; Michael Sofia; Timothy Block; Tianlun Zhou
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

5.  A bioinformatics investigation into molecular mechanism of Yinzhihuang granules for treating hepatitis B by network pharmacology and molecular docking verification.

Authors:  Jingyuan Zhang; Xinkui Liu; Wei Zhou; Guoliang Cheng; Jiarui Wu; Siyu Guo; Shanshan Jia; Yingying Liu; Bingbing Li; Xiaomeng Zhang; Miaomiao Wang
Journal:  Sci Rep       Date:  2020-07-10       Impact factor: 4.379

6.  The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element.

Authors:  Yanan Guo; He Lu; Lei Xu; Nur Fazleen Binti Idris; Yimin Li; Jieli Hu; Ailong Huang; Zeng Tu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.